Victory Capital Management
LMAT icon

Victory Capital Management’s LeMaitre Vascular LMAT Stock Holding History

Victory Capital Management’s Portfolio LMAT Stock Details LMAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$907K Sell
9,450
-1,460
-13% -$150K ﹤0.01% 1936
2026
Q1 		$1.19M Buy
10,910
+880
+9% +$83.9K ﹤0.01% 1769
2025
Q4 		$813K Sell
10,030
-9,370
-48% -$807K ﹤0.01% 1916
2025
Q3 		$1.7M Sell
19,400
-55,625
-74% -$4.97M ﹤0.01% 1645
2025
Q2 		$6.23M Sell
75,025
-4,846
-6% -$405K ﹤0.01% 1244
2025
Q1 		$6.7M Buy
79,871
+25,133
+46% +$2.34M 0.01% 1191
2024
Q4 		$5.04M Buy
54,738
+1,678
+3% +$161K 0.01% 1263
2024
Q3 		$4.93M Buy
53,060
+10,011
+23% +$867K ﹤0.01% 1273
2024
Q2 		$3.54M Sell
43,049
-31,839
-43% -$2.34M ﹤0.01% 1306
2024
Q1 		$4.97M Sell
74,888
-1,886
-2% -$116K ﹤0.01% 1234
2023
Q4 		$4.36M Sell
76,774
-141
-0.2% -$7.39K ﹤0.01% 1259
2023
Q3 		$4.19M Buy
76,915
+557
+0.7% +$33K ﹤0.01% 1241
2023
Q2 		$5.14M Sell
76,358
-28,542
-27% -$1.74M 0.01% 1198
2023
Q1 		$5.4M Sell
104,900
-25,931
-20% -$1.26M 0.01% 1190
2022
Q4 		$6.02M Sell
130,831
-22,820
-15% -$1.07M 0.01% 1161
2022
Q3 		$7.79M Sell
153,651
-15,227
-9% -$761K 0.01% 1129
2022
Q2 		$7.69M Sell
168,878
-4,116
-2% -$184K 0.01% 1145
2022
Q1 		$7.94M Buy
172,994
+2,362
+1% +$106K 0.01% 1181
2021
Q4 		$8.57M Buy
170,632
+4,183
+3% +$216K 0.01% 1172
2021
Q3 		$8.84M Buy
166,449
+1,632
+1% +$91.9K 0.01% 1135
2021
Q2 		$10.1M Sell
164,817
-1,515
-0.9% -$80.5K 0.01% 1129
2021
Q1 		$8.11M Buy
166,332
+158,982
+2,163% +$7.45M 0.01% 1198
2020
Q4 		$298K Sell
7,350
-357
-5% -$12.8K ﹤0.01% 2286
2020
Q3 		$251K Sell
7,707
-10,002
-56% -$300K ﹤0.01% 2223
2020
Q2 		$468K Sell
17,709
-4,314
-20% -$113K ﹤0.01% 2003
2020
Q1 		$549K Buy
22,023
+2,256
+11% +$69.7K ﹤0.01% 1808
2019
Q4 		$711K Buy
19,767
+12,313
+165% +$425K ﹤0.01% 1855
2019
Q3 		$255K Buy
7,454
+4,927
+195% +$157K ﹤0.01% 2136
2019
Q2 		$71K Sell
2,527
-4,394
-63% -$122K ﹤0.01% 1686
2019
Q1 		$215K Sell
6,921
-3,030
-30% -$80.9K ﹤0.01% 1546
2018
Q4 		$235K Buy
9,951
+387
+4% +$10.6K ﹤0.01% 1532
2018
Q3 		$371K Buy
9,564
+3,681
+63% +$133K ﹤0.01% 1493
2018
Q2 		$197K Buy
5,883
+807
+16% +$28.7K ﹤0.01% 1626
2018
Q1 		$184K Buy
5,076
+2,156
+74% +$74.7K ﹤0.01% 1620
2017
Q4 		$93K Sell
2,920
-1,219
-29% -$41.8K ﹤0.01% 1699
2017
Q3 		$155K Buy
4,139
+2,667
+181% +$90.8K ﹤0.01% 1622
2017
Q2 		$46K Sell
1,472
-736
-33% -$21.3K ﹤0.01% 1739
2017
Q1 		$54K Hold
2,208
– – ﹤0.01% 1727
2016
Q4 		$56K Buy
2,208
+307
+16% +$6.81K ﹤0.01% 1700
2016
Q3 		$38K Buy
+1,901
New +$33.2K ﹤0.01% 1726

Other funds holding LMAT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CCM
Copeland Capital Management Conshohocken, Pennsylvania $4.87B AUM 31.21% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Victory Capital Management's LMAT Position: Q2 2026 in Review

Victory Capital Management reduced its LeMaitre Vascular (LMAT) stake by 13% in Q2 2026, selling an estimated $150K and leaving 9,450 shares worth $907K. The position accounts for ﹤0.01% of the portfolio, ranked #1936.

Victory Capital Management first reported a position in LMAT in Q3 2016 and has held it in 40 quarters since. The position peaked at $10.1M in Q2 2021. 327 funds tracked by Wall St. Rank hold LMAT as of Q2 2026.

  • Victory Capital Management held 9,450 shares of LeMaitre Vascular worth $907K as of Q2 2026.
  • Victory Capital Management sold 1,460 LeMaitre Vascular shares in Q2 2026, an estimated $150K.
  • LeMaitre Vascular made up ﹤0.01% of Victory Capital Management's portfolio in Q2 2026, its #1936 holding.
  • Victory Capital Management first reported a position in LeMaitre Vascular in Q3 2016 and has held it in 40 quarters since.
  • Victory Capital Management's LeMaitre Vascular position peaked at $10.1M in Q2 2021.
  • 327 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q2 2026.

Based on Victory Capital Management's 13F filing for Q2 2026, filed 7 Aug 2026.